找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Human Monoclonal Antibodies; Methods and Protocol Michael Steinitz Book 2019Latest edition Springer Science+Business Media, LLC, part of Sp

[复制链接]
楼主: BULK
发表于 2025-3-27 00:50:57 | 显示全部楼层
发表于 2025-3-27 03:13:24 | 显示全部楼层
发表于 2025-3-27 08:35:22 | 显示全部楼层
Methods in Molecular Biologyhttp://image.papertrans.cn/h/image/429320.jpg
发表于 2025-3-27 10:11:54 | 显示全部楼层
发表于 2025-3-27 16:15:05 | 显示全部楼层
Springer Science+Business Media, LLC, part of Springer Nature 2019
发表于 2025-3-27 19:32:13 | 显示全部楼层
Human Monoclonal Antibodies978-1-4939-8958-4Series ISSN 1064-3745 Series E-ISSN 1940-6029
发表于 2025-3-28 00:01:43 | 显示全部楼层
Book 2019Latest editiond tips on troubleshooting and avoiding known pitfalls..Uniqueand thorough, .Human Monoclonal Antibodies: Methods and Protocols, Second Edition. is a valuable tool for novice and expert researchers interested in learning more about this evolving field..
发表于 2025-3-28 05:12:31 | 显示全部楼层
Human Monoclonal Antibodies: The Benefits of Humanization,aminating protein aggregates, or “aggregates” arising from antibodies complexing with their antigen. I here summarize our efforts to engineer antibodies to harness optimal effector functions, while also minimizing their immunogenicity. Potential avenues to achieve the latte are predicted from classi
发表于 2025-3-28 09:31:18 | 显示全部楼层
IgM Natural Autoantibodies in Physiology and the Treatment of Disease,different disease conditions such as atherosclerosis, cancer, and autoimmune disease. We also describe the discovery of two reparative IgM-NAAs by our laboratory and delineate their proposed mechanisms of action in central nervous system (CNS) disease.
发表于 2025-3-28 12:42:43 | 显示全部楼层
Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies,nse rates, low relapse rates and showed manageable safety profile. Antibodies against ligands for PD-1 receptors were then developed to overcome the adverse effects of anti-PD-1 antibodies and combination of monoclonal antibodies (ipilimumab plus nivolumab) was tested to increase the response rates.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 12:45
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表